Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)

American Journal of Cardiology

Volumn 92, Issue 7, 2003, Pages 779-784

  Kandzari, David E ^a   Tcheng, James E ^b   Cohen, David J ^b   Bakhai, Ameet ^b   Grines, Cindy L ^b   Cox, David A ^b   Effron, Mark ^b   Stuckey, Thomas ^b   Griffin, John J ^b   Turco, Mark ^b   Carroll, John D ^b   Fahy, Martin ^b   Mehran, Roxana ^b   Stone, Gregg W ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; CENTOCOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TOXICITY; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FEVER; HEART FAILURE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HIGH RISK POPULATION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVASCULARIZATION; SHOCK; SIDE EFFECT; STROKE; THORAX PAIN; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0141682431     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00882-8     Document Type: Article

References (14)

1. Grines C.L., Marsalese D.L., Brodie B., Griffin J., Donohue B., Costantini C.R., Balestrini C., Stone G., Wharton T., Esente P., et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 31:1998;967-972.
2. Guerci A.D. Early discharge after acute myocardial infarction who and when? J Am Coll Cardiol. 33:1999;1047-1049.
3. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van de Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction results from an international trial of 41, 021 patients . Circulation. 91:1995;1659-1668.
4. Appleby P., Baigent C., Collins R., Flather M., Parish S., Peto R. Indications for fibrinolytic therapy suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients . Lancet. 343:1994;311-322.
5. Wilkinson P., Stevenson R., Ranjadayalan K., Marchant B., Roberts R., Timmis A.D. Early discharge after acute myocardial infarction risks and benefits . Br Heart J. 74:1995;71-75.
6. Newby L.K., Califf R.M., Guerci A., Weaver W.D., Col J., Horgan J.H., Mark D.B., Stebbins A., Van de Werf F., Gore J.M., Topol E.J. Early discharge in the thrombolytic era an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial . J Am Coll Cardiol. 27:1996;625-632.
7. Brener S.J., Barr L.A., Burchenal J.E., Katz S., George B.S., Jones A.A., Cohen E.D., Gainey P.C., White H.J., Cheek H.B., et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 98:1998;734-741.
8. Neumann F.J., Kastrati A., Schmitt C., Blasini R., Hadamitzky M., Mehilli J., Gawaz M., Schleef M., Seyfarth M., Dirschinger J., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol. 35:2000;915-921.
9. Montalescot G., Barragan P., Wittenberg O., Ecollan P., Elhadad S., Villain P., Boulenc J.M., Morice M.C., Maillard L., Pansieri M., Choussat R., Pinton P. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 344:2001;1895-1903.
10. Stone G.W., Grines C.L., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Carroll J.D., Rutherford B.D., Lansky A.J. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 346:2002;957-966.
11. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giambartolomei A., Brodie B.R., Madonna O., Eijgelshoven M., Lansky A.J., O'Neill W.W., Morice M.C. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 341:1999;1949-1956.
12. Stone G.W., Brodie B.R., Griffin J.J., Grines L., Boura J., O'Neill W.W., Grines C.L. Clinical and angiographic outcomes in patients with previous coronary artery bypass surgery treated with primary balloon angioplasty for acute myocardial infarction. J Am Coll Cardiol. 35:2000;605-611.
13. Topol E.J., Burek K., O'Neill W.W., Kewman D. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med. 318:1988;1083-1088.
14. Senaratne M.P., Irwin M.E., Shaben S., Griffiths J., Nagendran J., Kasza L., Gulamhusein S., Haughian M. Feasibility of direct discharge from the coronary/intermediate care unit after acute myocardial infarction. J Am Coll Cardiol. 33:1999;1040-1046.